nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—ABCC2—Sorafenib—thyroid cancer	0.309	0.622	CbGbCtD
Olmesartan—ABCC2—Doxorubicin—thyroid cancer	0.188	0.378	CbGbCtD
Olmesartan—Telmisartan—PPARG—thyroid cancer	0.00626	1	CrCbGaD
Olmesartan—Loss of consciousness—Sorafenib—thyroid cancer	0.00142	0.00285	CcSEcCtD
Olmesartan—Cough—Sorafenib—thyroid cancer	0.0014	0.00283	CcSEcCtD
Olmesartan—Asthenia—Vandetanib—thyroid cancer	0.0014	0.00281	CcSEcCtD
Olmesartan—Viral infection—Doxorubicin—thyroid cancer	0.00139	0.0028	CcSEcCtD
Olmesartan—Blood uric acid increased—Epirubicin—thyroid cancer	0.00139	0.00279	CcSEcCtD
Olmesartan—Hyperbilirubinaemia—Doxorubicin—thyroid cancer	0.00138	0.00279	CcSEcCtD
Olmesartan—Pruritus—Vandetanib—thyroid cancer	0.00138	0.00277	CcSEcCtD
Olmesartan—Arthralgia—Sorafenib—thyroid cancer	0.00137	0.00276	CcSEcCtD
Olmesartan—Myalgia—Sorafenib—thyroid cancer	0.00137	0.00276	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00136	0.00274	CcSEcCtD
Olmesartan—Hyperuricaemia—Doxorubicin—thyroid cancer	0.00136	0.00273	CcSEcCtD
Olmesartan—Hyperkalaemia—Epirubicin—thyroid cancer	0.00134	0.00269	CcSEcCtD
Olmesartan—Diarrhoea—Vandetanib—thyroid cancer	0.00133	0.00268	CcSEcCtD
Olmesartan—Blood bilirubin increased—Doxorubicin—thyroid cancer	0.00133	0.00268	CcSEcCtD
Olmesartan—Influenza like illness—Epirubicin—thyroid cancer	0.00132	0.00266	CcSEcCtD
Olmesartan—Bone pain—Doxorubicin—thyroid cancer	0.00131	0.00264	CcSEcCtD
Olmesartan—Anaphylactic shock—Sorafenib—thyroid cancer	0.00131	0.00264	CcSEcCtD
Olmesartan—Infection—Sorafenib—thyroid cancer	0.00131	0.00263	CcSEcCtD
Olmesartan—Shock—Sorafenib—thyroid cancer	0.00129	0.0026	CcSEcCtD
Olmesartan—Nervous system disorder—Sorafenib—thyroid cancer	0.00129	0.00259	CcSEcCtD
Olmesartan—Dizziness—Vandetanib—thyroid cancer	0.00129	0.00259	CcSEcCtD
Olmesartan—Thrombocytopenia—Sorafenib—thyroid cancer	0.00129	0.00259	CcSEcCtD
Olmesartan—Blood urea increased—Epirubicin—thyroid cancer	0.00129	0.00258	CcSEcCtD
Olmesartan—Blood uric acid increased—Doxorubicin—thyroid cancer	0.00128	0.00258	CcSEcCtD
Olmesartan—Aplastic anaemia—Epirubicin—thyroid cancer	0.00128	0.00257	CcSEcCtD
Olmesartan—Skin disorder—Sorafenib—thyroid cancer	0.00128	0.00257	CcSEcCtD
Olmesartan—Anorexia—Sorafenib—thyroid cancer	0.00125	0.00252	CcSEcCtD
Olmesartan—Vomiting—Vandetanib—thyroid cancer	0.00124	0.00249	CcSEcCtD
Olmesartan—Hyperkalaemia—Doxorubicin—thyroid cancer	0.00124	0.00249	CcSEcCtD
Olmesartan—Rash—Vandetanib—thyroid cancer	0.00123	0.00247	CcSEcCtD
Olmesartan—Dermatitis—Vandetanib—thyroid cancer	0.00123	0.00247	CcSEcCtD
Olmesartan—Influenza like illness—Doxorubicin—thyroid cancer	0.00122	0.00246	CcSEcCtD
Olmesartan—Headache—Vandetanib—thyroid cancer	0.00122	0.00245	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.0012	0.00241	CcSEcCtD
Olmesartan—Blood urea increased—Doxorubicin—thyroid cancer	0.00119	0.00239	CcSEcCtD
Olmesartan—Aplastic anaemia—Doxorubicin—thyroid cancer	0.00118	0.00238	CcSEcCtD
Olmesartan—Nausea—Vandetanib—thyroid cancer	0.00116	0.00233	CcSEcCtD
Olmesartan—Dyspepsia—Sorafenib—thyroid cancer	0.00116	0.00233	CcSEcCtD
Olmesartan—Decreased appetite—Sorafenib—thyroid cancer	0.00114	0.0023	CcSEcCtD
Olmesartan—Diabetes mellitus—Epirubicin—thyroid cancer	0.00114	0.00228	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00113	0.00228	CcSEcCtD
Olmesartan—Fatigue—Sorafenib—thyroid cancer	0.00113	0.00228	CcSEcCtD
Olmesartan—Pain—Sorafenib—thyroid cancer	0.00112	0.00226	CcSEcCtD
Olmesartan—Constipation—Sorafenib—thyroid cancer	0.00112	0.00226	CcSEcCtD
Olmesartan—Eczema—Epirubicin—thyroid cancer	0.0011	0.00221	CcSEcCtD
Olmesartan—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00107	0.00216	CcSEcCtD
Olmesartan—Renal failure acute—Epirubicin—thyroid cancer	0.00107	0.00215	CcSEcCtD
Olmesartan—Diabetes mellitus—Doxorubicin—thyroid cancer	0.00105	0.00211	CcSEcCtD
Olmesartan—Urticaria—Sorafenib—thyroid cancer	0.00104	0.0021	CcSEcCtD
Olmesartan—Abdominal pain—Sorafenib—thyroid cancer	0.00104	0.00209	CcSEcCtD
Olmesartan—Body temperature increased—Sorafenib—thyroid cancer	0.00104	0.00209	CcSEcCtD
Olmesartan—Eczema—Doxorubicin—thyroid cancer	0.00102	0.00205	CcSEcCtD
Olmesartan—Lethargy—Epirubicin—thyroid cancer	0.00101	0.00203	CcSEcCtD
Olmesartan—Hyponatraemia—Epirubicin—thyroid cancer	0.000992	0.002	CcSEcCtD
Olmesartan—Renal failure acute—Doxorubicin—thyroid cancer	0.00099	0.00199	CcSEcCtD
Olmesartan—Pain in extremity—Epirubicin—thyroid cancer	0.000988	0.00199	CcSEcCtD
Olmesartan—Face oedema—Epirubicin—thyroid cancer	0.000954	0.00192	CcSEcCtD
Olmesartan—Asthenia—Sorafenib—thyroid cancer	0.000943	0.0019	CcSEcCtD
Olmesartan—Lethargy—Doxorubicin—thyroid cancer	0.000933	0.00188	CcSEcCtD
Olmesartan—Pruritus—Sorafenib—thyroid cancer	0.00093	0.00187	CcSEcCtD
Olmesartan—Blood creatinine increased—Epirubicin—thyroid cancer	0.000926	0.00186	CcSEcCtD
Olmesartan—Hyponatraemia—Doxorubicin—thyroid cancer	0.000918	0.00185	CcSEcCtD
Olmesartan—Pain in extremity—Doxorubicin—thyroid cancer	0.000914	0.00184	CcSEcCtD
Olmesartan—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000902	0.00181	CcSEcCtD
Olmesartan—Hypokalaemia—Epirubicin—thyroid cancer	0.000899	0.00181	CcSEcCtD
Olmesartan—Diarrhoea—Sorafenib—thyroid cancer	0.000899	0.00181	CcSEcCtD
Olmesartan—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00089	0.00179	CcSEcCtD
Olmesartan—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00089	0.00179	CcSEcCtD
Olmesartan—Nasopharyngitis—Epirubicin—thyroid cancer	0.000884	0.00178	CcSEcCtD
Olmesartan—Face oedema—Doxorubicin—thyroid cancer	0.000883	0.00178	CcSEcCtD
Olmesartan—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000871	0.00175	CcSEcCtD
Olmesartan—Dizziness—Sorafenib—thyroid cancer	0.000869	0.00175	CcSEcCtD
Olmesartan—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000856	0.00172	CcSEcCtD
Olmesartan—Influenza—Epirubicin—thyroid cancer	0.000854	0.00172	CcSEcCtD
Olmesartan—Eosinophilia—Epirubicin—thyroid cancer	0.000846	0.0017	CcSEcCtD
Olmesartan—Pancreatitis—Epirubicin—thyroid cancer	0.000837	0.00168	CcSEcCtD
Olmesartan—Vomiting—Sorafenib—thyroid cancer	0.000835	0.00168	CcSEcCtD
Olmesartan—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000835	0.00168	CcSEcCtD
Olmesartan—Hypokalaemia—Doxorubicin—thyroid cancer	0.000832	0.00167	CcSEcCtD
Olmesartan—Angina pectoris—Epirubicin—thyroid cancer	0.000832	0.00167	CcSEcCtD
Olmesartan—Rash—Sorafenib—thyroid cancer	0.000829	0.00167	CcSEcCtD
Olmesartan—Dermatitis—Sorafenib—thyroid cancer	0.000828	0.00166	CcSEcCtD
Olmesartan—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000823	0.00166	CcSEcCtD
Olmesartan—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000823	0.00166	CcSEcCtD
Olmesartan—Headache—Sorafenib—thyroid cancer	0.000823	0.00166	CcSEcCtD
Olmesartan—Bronchitis—Epirubicin—thyroid cancer	0.000821	0.00165	CcSEcCtD
Olmesartan—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000818	0.00164	CcSEcCtD
Olmesartan—Pancytopenia—Epirubicin—thyroid cancer	0.000811	0.00163	CcSEcCtD
Olmesartan—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000806	0.00162	CcSEcCtD
Olmesartan—Neutropenia—Epirubicin—thyroid cancer	0.000799	0.00161	CcSEcCtD
Olmesartan—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000794	0.0016	CcSEcCtD
Olmesartan—Influenza—Doxorubicin—thyroid cancer	0.00079	0.00159	CcSEcCtD
Olmesartan—Eosinophilia—Doxorubicin—thyroid cancer	0.000782	0.00157	CcSEcCtD
Olmesartan—Nausea—Sorafenib—thyroid cancer	0.000781	0.00157	CcSEcCtD
Olmesartan—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000779	0.00157	CcSEcCtD
Olmesartan—Pancreatitis—Doxorubicin—thyroid cancer	0.000775	0.00156	CcSEcCtD
Olmesartan—Hyperglycaemia—Epirubicin—thyroid cancer	0.00077	0.00155	CcSEcCtD
Olmesartan—Angina pectoris—Doxorubicin—thyroid cancer	0.00077	0.00155	CcSEcCtD
Olmesartan—Pneumonia—Epirubicin—thyroid cancer	0.000766	0.00154	CcSEcCtD
Olmesartan—Infestation—Epirubicin—thyroid cancer	0.000761	0.00153	CcSEcCtD
Olmesartan—Infestation NOS—Epirubicin—thyroid cancer	0.000761	0.00153	CcSEcCtD
Olmesartan—Bronchitis—Doxorubicin—thyroid cancer	0.00076	0.00153	CcSEcCtD
Olmesartan—Pancytopenia—Doxorubicin—thyroid cancer	0.00075	0.00151	CcSEcCtD
Olmesartan—Renal failure—Epirubicin—thyroid cancer	0.000748	0.00151	CcSEcCtD
Olmesartan—Jaundice—Epirubicin—thyroid cancer	0.000742	0.00149	CcSEcCtD
Olmesartan—Urinary tract infection—Epirubicin—thyroid cancer	0.00074	0.00149	CcSEcCtD
Olmesartan—Neutropenia—Doxorubicin—thyroid cancer	0.000739	0.00149	CcSEcCtD
Olmesartan—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000734	0.00148	CcSEcCtD
Olmesartan—Haematuria—Epirubicin—thyroid cancer	0.000726	0.00146	CcSEcCtD
Olmesartan—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000721	0.00145	CcSEcCtD
Olmesartan—Sinusitis—Epirubicin—thyroid cancer	0.000714	0.00144	CcSEcCtD
Olmesartan—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000713	0.00143	CcSEcCtD
Olmesartan—Agranulocytosis—Epirubicin—thyroid cancer	0.000711	0.00143	CcSEcCtD
Olmesartan—Pneumonia—Doxorubicin—thyroid cancer	0.000709	0.00143	CcSEcCtD
Olmesartan—Infestation NOS—Doxorubicin—thyroid cancer	0.000705	0.00142	CcSEcCtD
Olmesartan—Infestation—Doxorubicin—thyroid cancer	0.000705	0.00142	CcSEcCtD
Olmesartan—Renal failure—Doxorubicin—thyroid cancer	0.000693	0.00139	CcSEcCtD
Olmesartan—Jaundice—Doxorubicin—thyroid cancer	0.000687	0.00138	CcSEcCtD
Olmesartan—Rhinitis—Epirubicin—thyroid cancer	0.000685	0.00138	CcSEcCtD
Olmesartan—Urinary tract infection—Doxorubicin—thyroid cancer	0.000685	0.00138	CcSEcCtD
Olmesartan—Pharyngitis—Epirubicin—thyroid cancer	0.000678	0.00136	CcSEcCtD
Olmesartan—Urinary tract disorder—Epirubicin—thyroid cancer	0.000675	0.00136	CcSEcCtD
Olmesartan—Oedema peripheral—Epirubicin—thyroid cancer	0.000673	0.00135	CcSEcCtD
Olmesartan—Haematuria—Doxorubicin—thyroid cancer	0.000672	0.00135	CcSEcCtD
Olmesartan—Connective tissue disorder—Epirubicin—thyroid cancer	0.000672	0.00135	CcSEcCtD
Olmesartan—Urethral disorder—Epirubicin—thyroid cancer	0.00067	0.00135	CcSEcCtD
Olmesartan—Sinusitis—Doxorubicin—thyroid cancer	0.000661	0.00133	CcSEcCtD
Olmesartan—Agranulocytosis—Doxorubicin—thyroid cancer	0.000657	0.00132	CcSEcCtD
Olmesartan—Rhinitis—Doxorubicin—thyroid cancer	0.000634	0.00128	CcSEcCtD
Olmesartan—Pharyngitis—Doxorubicin—thyroid cancer	0.000628	0.00126	CcSEcCtD
Olmesartan—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000625	0.00126	CcSEcCtD
Olmesartan—Oedema peripheral—Doxorubicin—thyroid cancer	0.000623	0.00125	CcSEcCtD
Olmesartan—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000622	0.00125	CcSEcCtD
Olmesartan—Angiopathy—Epirubicin—thyroid cancer	0.00062	0.00125	CcSEcCtD
Olmesartan—Urethral disorder—Doxorubicin—thyroid cancer	0.00062	0.00125	CcSEcCtD
Olmesartan—Mediastinal disorder—Epirubicin—thyroid cancer	0.000616	0.00124	CcSEcCtD
Olmesartan—Arrhythmia—Epirubicin—thyroid cancer	0.000611	0.00123	CcSEcCtD
Olmesartan—Alopecia—Epirubicin—thyroid cancer	0.000604	0.00121	CcSEcCtD
Olmesartan—Mental disorder—Epirubicin—thyroid cancer	0.000599	0.0012	CcSEcCtD
Olmesartan—Malnutrition—Epirubicin—thyroid cancer	0.000595	0.0012	CcSEcCtD
Olmesartan—Back pain—Epirubicin—thyroid cancer	0.000576	0.00116	CcSEcCtD
Olmesartan—Angiopathy—Doxorubicin—thyroid cancer	0.000574	0.00115	CcSEcCtD
Olmesartan—Muscle spasms—Epirubicin—thyroid cancer	0.000572	0.00115	CcSEcCtD
Olmesartan—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00057	0.00115	CcSEcCtD
Olmesartan—Arrhythmia—Doxorubicin—thyroid cancer	0.000565	0.00114	CcSEcCtD
Olmesartan—Vision blurred—Epirubicin—thyroid cancer	0.000561	0.00113	CcSEcCtD
Olmesartan—Alopecia—Doxorubicin—thyroid cancer	0.000559	0.00112	CcSEcCtD
Olmesartan—Mental disorder—Doxorubicin—thyroid cancer	0.000554	0.00111	CcSEcCtD
Olmesartan—Ill-defined disorder—Epirubicin—thyroid cancer	0.000552	0.00111	CcSEcCtD
Olmesartan—Malnutrition—Doxorubicin—thyroid cancer	0.000551	0.00111	CcSEcCtD
Olmesartan—Anaemia—Epirubicin—thyroid cancer	0.00055	0.00111	CcSEcCtD
Olmesartan—Agitation—Epirubicin—thyroid cancer	0.000547	0.0011	CcSEcCtD
Olmesartan—Malaise—Epirubicin—thyroid cancer	0.000537	0.00108	CcSEcCtD
Olmesartan—Vertigo—Epirubicin—thyroid cancer	0.000535	0.00108	CcSEcCtD
Olmesartan—Syncope—Epirubicin—thyroid cancer	0.000534	0.00107	CcSEcCtD
Olmesartan—Leukopenia—Epirubicin—thyroid cancer	0.000533	0.00107	CcSEcCtD
Olmesartan—Back pain—Doxorubicin—thyroid cancer	0.000533	0.00107	CcSEcCtD
Olmesartan—Muscle spasms—Doxorubicin—thyroid cancer	0.000529	0.00106	CcSEcCtD
Olmesartan—Palpitations—Epirubicin—thyroid cancer	0.000526	0.00106	CcSEcCtD
Olmesartan—Loss of consciousness—Epirubicin—thyroid cancer	0.000523	0.00105	CcSEcCtD
Olmesartan—Cough—Epirubicin—thyroid cancer	0.000519	0.00104	CcSEcCtD
Olmesartan—Vision blurred—Doxorubicin—thyroid cancer	0.000519	0.00104	CcSEcCtD
Olmesartan—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000511	0.00103	CcSEcCtD
Olmesartan—Anaemia—Doxorubicin—thyroid cancer	0.000509	0.00102	CcSEcCtD
Olmesartan—Arthralgia—Epirubicin—thyroid cancer	0.000507	0.00102	CcSEcCtD
Olmesartan—Chest pain—Epirubicin—thyroid cancer	0.000507	0.00102	CcSEcCtD
Olmesartan—Myalgia—Epirubicin—thyroid cancer	0.000507	0.00102	CcSEcCtD
Olmesartan—Agitation—Doxorubicin—thyroid cancer	0.000506	0.00102	CcSEcCtD
Olmesartan—Anxiety—Epirubicin—thyroid cancer	0.000505	0.00102	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000503	0.00101	CcSEcCtD
Olmesartan—Discomfort—Epirubicin—thyroid cancer	0.000501	0.00101	CcSEcCtD
Olmesartan—Malaise—Doxorubicin—thyroid cancer	0.000496	0.000999	CcSEcCtD
Olmesartan—Vertigo—Doxorubicin—thyroid cancer	0.000495	0.000995	CcSEcCtD
Olmesartan—Syncope—Doxorubicin—thyroid cancer	0.000494	0.000993	CcSEcCtD
Olmesartan—Leukopenia—Doxorubicin—thyroid cancer	0.000493	0.000991	CcSEcCtD
Olmesartan—Palpitations—Doxorubicin—thyroid cancer	0.000487	0.000979	CcSEcCtD
Olmesartan—Anaphylactic shock—Epirubicin—thyroid cancer	0.000486	0.000977	CcSEcCtD
Olmesartan—Oedema—Epirubicin—thyroid cancer	0.000486	0.000977	CcSEcCtD
Olmesartan—Loss of consciousness—Doxorubicin—thyroid cancer	0.000484	0.000973	CcSEcCtD
Olmesartan—Infection—Epirubicin—thyroid cancer	0.000482	0.00097	CcSEcCtD
Olmesartan—Cough—Doxorubicin—thyroid cancer	0.00048	0.000966	CcSEcCtD
Olmesartan—Shock—Epirubicin—thyroid cancer	0.000478	0.000961	CcSEcCtD
Olmesartan—Nervous system disorder—Epirubicin—thyroid cancer	0.000476	0.000958	CcSEcCtD
Olmesartan—Thrombocytopenia—Epirubicin—thyroid cancer	0.000475	0.000956	CcSEcCtD
Olmesartan—Tachycardia—Epirubicin—thyroid cancer	0.000474	0.000953	CcSEcCtD
Olmesartan—Skin disorder—Epirubicin—thyroid cancer	0.000472	0.000949	CcSEcCtD
Olmesartan—Hyperhidrosis—Epirubicin—thyroid cancer	0.000469	0.000944	CcSEcCtD
Olmesartan—Arthralgia—Doxorubicin—thyroid cancer	0.000469	0.000943	CcSEcCtD
Olmesartan—Chest pain—Doxorubicin—thyroid cancer	0.000469	0.000943	CcSEcCtD
Olmesartan—Myalgia—Doxorubicin—thyroid cancer	0.000469	0.000943	CcSEcCtD
Olmesartan—Anxiety—Doxorubicin—thyroid cancer	0.000467	0.000939	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000466	0.000936	CcSEcCtD
Olmesartan—Discomfort—Doxorubicin—thyroid cancer	0.000463	0.000931	CcSEcCtD
Olmesartan—Anorexia—Epirubicin—thyroid cancer	0.000463	0.000931	CcSEcCtD
Olmesartan—Hypotension—Epirubicin—thyroid cancer	0.000454	0.000913	CcSEcCtD
Olmesartan—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000449	0.000904	CcSEcCtD
Olmesartan—Oedema—Doxorubicin—thyroid cancer	0.000449	0.000904	CcSEcCtD
Olmesartan—Infection—Doxorubicin—thyroid cancer	0.000446	0.000898	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000442	0.00089	CcSEcCtD
Olmesartan—Shock—Doxorubicin—thyroid cancer	0.000442	0.000889	CcSEcCtD
Olmesartan—Nervous system disorder—Doxorubicin—thyroid cancer	0.000441	0.000886	CcSEcCtD
Olmesartan—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00044	0.000885	CcSEcCtD
Olmesartan—Insomnia—Epirubicin—thyroid cancer	0.000439	0.000883	CcSEcCtD
Olmesartan—Tachycardia—Doxorubicin—thyroid cancer	0.000439	0.000882	CcSEcCtD
Olmesartan—Skin disorder—Doxorubicin—thyroid cancer	0.000436	0.000878	CcSEcCtD
Olmesartan—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000434	0.000874	CcSEcCtD
Olmesartan—Anorexia—Doxorubicin—thyroid cancer	0.000428	0.000861	CcSEcCtD
Olmesartan—Dyspepsia—Epirubicin—thyroid cancer	0.000427	0.00086	CcSEcCtD
Olmesartan—Decreased appetite—Epirubicin—thyroid cancer	0.000422	0.000849	CcSEcCtD
Olmesartan—Hypotension—Doxorubicin—thyroid cancer	0.00042	0.000844	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000419	0.000843	CcSEcCtD
Olmesartan—Fatigue—Epirubicin—thyroid cancer	0.000419	0.000842	CcSEcCtD
Olmesartan—Constipation—Epirubicin—thyroid cancer	0.000415	0.000835	CcSEcCtD
Olmesartan—Pain—Epirubicin—thyroid cancer	0.000415	0.000835	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000409	0.000823	CcSEcCtD
Olmesartan—Insomnia—Doxorubicin—thyroid cancer	0.000406	0.000817	CcSEcCtD
Olmesartan—Feeling abnormal—Epirubicin—thyroid cancer	0.0004	0.000805	CcSEcCtD
Olmesartan—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000397	0.000799	CcSEcCtD
Olmesartan—Dyspepsia—Doxorubicin—thyroid cancer	0.000396	0.000795	CcSEcCtD
Olmesartan—Decreased appetite—Doxorubicin—thyroid cancer	0.000391	0.000786	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000388	0.00078	CcSEcCtD
Olmesartan—Fatigue—Doxorubicin—thyroid cancer	0.000387	0.000779	CcSEcCtD
Olmesartan—Urticaria—Epirubicin—thyroid cancer	0.000386	0.000776	CcSEcCtD
Olmesartan—Constipation—Doxorubicin—thyroid cancer	0.000384	0.000773	CcSEcCtD
Olmesartan—Pain—Doxorubicin—thyroid cancer	0.000384	0.000773	CcSEcCtD
Olmesartan—Abdominal pain—Epirubicin—thyroid cancer	0.000384	0.000772	CcSEcCtD
Olmesartan—Body temperature increased—Epirubicin—thyroid cancer	0.000384	0.000772	CcSEcCtD
Olmesartan—Feeling abnormal—Doxorubicin—thyroid cancer	0.00037	0.000745	CcSEcCtD
Olmesartan—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000367	0.000739	CcSEcCtD
Olmesartan—Urticaria—Doxorubicin—thyroid cancer	0.000357	0.000718	CcSEcCtD
Olmesartan—Abdominal pain—Doxorubicin—thyroid cancer	0.000355	0.000714	CcSEcCtD
Olmesartan—Body temperature increased—Doxorubicin—thyroid cancer	0.000355	0.000714	CcSEcCtD
Olmesartan—Asthenia—Epirubicin—thyroid cancer	0.000348	0.000701	CcSEcCtD
Olmesartan—Pruritus—Epirubicin—thyroid cancer	0.000344	0.000691	CcSEcCtD
Olmesartan—Diarrhoea—Epirubicin—thyroid cancer	0.000332	0.000668	CcSEcCtD
Olmesartan—Asthenia—Doxorubicin—thyroid cancer	0.000322	0.000648	CcSEcCtD
Olmesartan—Dizziness—Epirubicin—thyroid cancer	0.000321	0.000646	CcSEcCtD
Olmesartan—Pruritus—Doxorubicin—thyroid cancer	0.000318	0.000639	CcSEcCtD
Olmesartan—Vomiting—Epirubicin—thyroid cancer	0.000309	0.000621	CcSEcCtD
Olmesartan—Diarrhoea—Doxorubicin—thyroid cancer	0.000307	0.000618	CcSEcCtD
Olmesartan—Rash—Epirubicin—thyroid cancer	0.000306	0.000616	CcSEcCtD
Olmesartan—Dermatitis—Epirubicin—thyroid cancer	0.000306	0.000615	CcSEcCtD
Olmesartan—Headache—Epirubicin—thyroid cancer	0.000304	0.000612	CcSEcCtD
Olmesartan—Dizziness—Doxorubicin—thyroid cancer	0.000297	0.000598	CcSEcCtD
Olmesartan—Nausea—Epirubicin—thyroid cancer	0.000288	0.00058	CcSEcCtD
Olmesartan—Vomiting—Doxorubicin—thyroid cancer	0.000286	0.000575	CcSEcCtD
Olmesartan—Rash—Doxorubicin—thyroid cancer	0.000283	0.00057	CcSEcCtD
Olmesartan—Dermatitis—Doxorubicin—thyroid cancer	0.000283	0.000569	CcSEcCtD
Olmesartan—Headache—Doxorubicin—thyroid cancer	0.000281	0.000566	CcSEcCtD
Olmesartan—Nausea—Doxorubicin—thyroid cancer	0.000267	0.000537	CcSEcCtD
